Medtronic reports second quarter fiscal 2025 financial results

Delivering on commitments, executing ahead of expectations, and raising guidance innovation driving sustained growth across many franchises:  tavr, pfa, leadless pacemakers, diabetes, spine, and neuromodulation galway, ireland , nov. 19, 2024 /prnewswire/ -- medtronic plc (nyse: mdt) today announced financial results for its second quarter (q2) of fiscal year 2025 (fy25), which ended october 25, 2024. key highlights revenue of $8.4 billion increased 5.3% as reported and 5.0% organic gaap diluted earnings per share (eps) of $0.99; non-gaap diluted eps of $1.26 company raises fy25 organic revenue growth and eps guidance financial results medtronic reported q2 worldwide revenue of $8.403 billion, an increase of 5.3% as reported and 5.0% on an organic basis.
MDT Ratings Summary
MDT Quant Ranking